Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.67USD
19 Oct 2018
Change (% chg)

$-0.02 (-1.18%)
Prev Close
$1.69
Open
$1.70
Day's High
$1.77
Day's Low
$1.67
Volume
3,509
Avg. Vol
3,420
52-wk High
$4.21
52-wk Low
$1.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.39 -0.075
Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. 9.46 287.36 45.19
P/E Low - Last 5 Yrs. 9.46 89.75 23.75
Beta -0.19 0.93 0.88
Price to Sales (TTM) 13.52 124.37 5.83
Price to Book (MRQ) 8.54 15.29 4.89
Price to Tangible Book (MRQ) 8.54 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 4.64 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -7.80 103.65 5.80
Sales - 5 Yr. Growth Rate -16.73 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -59.84 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 5.16 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -579.09 11.01
Operating Margin (TTM) -197.09 -786.66 4.07
Operating Margin - 5 Yr. Avg. -320.58 -600.20 6.34
Pre-Tax Margin (TTM) -253.47 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -264.44 -605.79 6.78
Net Profit Margin (TTM) -253.47 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -264.44 -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 22,677,535 808,218,600
Net Income/Employee (TTM) -492,081 1,703,754 95,058,584
Receivable Turnover (TTM) 4.40 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.19 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 -1.39 10.90
Return on Assets - 5 Yr. Avg. -57.32 3.03 12.01
Return on Investment (TTM) -119.26 0.21 14.27
Return on Investment - 5 Yr. Avg. -262.99 2.10 15.60
Return on Equity (TTM) -119.07 1.17 15.99
Return on Equity - 5 Yr. Avg. -367.36 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.00%
# of Holders: 23
Total Shares Held: 677,404
3 Mo. Net Change: 541
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.